2012, Number S3
PDF size: 101.61 Kb.
Text ExtractionNo abstract
Laferrece B, Heshka S, Wank k, et al. Incretin level an effect are markedly enhanced 1 month after Roux en Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709-1716.
Cummings S, Apovian C, Khaodhiar L. Obesity surgery: evidence for diabetes prevention management. J Am Diet Asoc 2008; 108: S40-44.
Richardson D, Vinik A. Metabolic implications of obesity: Before and after gastric bypass. Gastroenterol Clin N Am 2005; 34: 9-24.
Gil A. Pantoja-Millán JP. Cirugía metabólica. Cirugía Endoscópica 2008; 9: 183-187.
Hamplel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk of gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211.
Sauerland S, Angrisani L, Belachew M, et al. European Association for Endoscopic Surgery. Obesity Surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2005; 19: 200-221.
Feitoza AB, Baron TH. Endoscopy and ERCP in the setting of previous upper GI tract surgery. Part I: postsurgical anatomy without alteration of the pancreaticobiliary tree. Gastrointest Endosc 2001; 54: 743-749.
ASGE Guidelines. Role of endoscopy in the bariatric surgery patient. Gastrointest Endosc 2008;68:1-10.
Keith JN. Endoscopic management of common bariatric surgical complications. Gastrointest Endoscopy Clin N Am 2011; 21: 275-285.
Abu Dayyeh BK, Jirapinyo P, Weitzner Z, et al. Endoscopic sclerotherapy for the treatment of weight regain after Roux-en-Y gastric bypass: outcomes, complications, and predictors of response in 575 procedures. Gastrointest Endosc 2012; 76: 275-282.